Biocon sells 1.88 per cent stake in Syngene for Rs 230 crore

In a separate filing, Syngene said Biocon has sold the shares for achieving minimum public shareholding requirement.

Published: 18th May 2018 02:43 PM  |   Last Updated: 18th May 2018 02:43 PM   |  A+A-

An employee of Biocon Ltd works inside the company's research and development centre in Bengaluru, India. (File photo | Reuters)

By PTI

New Delhi, May 18 (PTI) Biocon Ltd has sold close to 2 per cent stake in its research arm Syngene International for an estimated Rs 230 crore.

"Biocon, the promoter of Syngene International, on May 16, 2018 has sold 37,65,574 equity shares amounting to 1.88 per cent of the equity share capital of Syngene through open market sale," Biocon said in a regulatory filing.

In a separate filing, Syngene said Biocon has sold the shares for achieving minimum public shareholding requirement.

Based on average weighted price of Syngene's shares on May 16 at Rs 611.02 apiece, the transaction is estimated at Rs 230.08 crore. ​Post transaction, stake of promoter and promoter group in the company stands at 72.57 per cent.Public shareholding is 25.90 per cent.

Shares of Syngene International were trading 0.36 per cent lower at Rs 605.20 apiece on BSE.

Stay up to date on all the latest Business news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL2018